Recurrent pericarditis: current challenges and future prospects
Claire Dauphin,1 Etienne Merlin,2 Aurélie Chalard,1 Romain Trésorier,1 Jean-René Lusson,1 Martin Soubrier3 1Department of Cardiology and Cardiovascular Diseases, 2Department of Pediatrics, 3Department of Rheumatology, Clermont ...
Dauphin C +5 more
doaj +3 more sources
Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis. [PDF]
Brucato A +14 more
europepmc +3 more sources
Recurrent Pericarditis: A Rare Adverse Effect of Mesalamine. [PDF]
Karki P, Kunwar A, Sharma N, Dogra M.
europepmc +3 more sources
Correction: Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis. [PDF]
europepmc +3 more sources
IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent Pericarditis. [PDF]
Wu MA +14 more
europepmc +2 more sources
Tolicizumab: a new option for refractory idiopathic recurrent pericarditis: a case report. [PDF]
Collini V +4 more
europepmc +3 more sources
The Role of Rilonacept in Recurrent Pericarditis. [PDF]
Presti SL +4 more
europepmc +3 more sources
Rilonacept and Anakinra in Recurrent Pericarditis: A Systematic Review and Meta-Analysis. [PDF]
Affas ZR +12 more
europepmc +3 more sources
Long-Standing Chronic Recurrent Pericarditis Managed With Advanced Diagnostic and Therapeutic Methods. [PDF]
Majid M +4 more
europepmc +2 more sources
Lessons From Genetics About the Interleukin 1 Gene and Treatment of Recurrent Pericarditis. [PDF]
Weber B, Honigberg MC.
europepmc +3 more sources

